Atlas Trials

Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation

Clinical trial NCT04338529 · COMPLETED

Trial details

NCT number
NCT04338529
Sponsor
251 Hellenic Air Force & VA General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Postmenopausal Osteoporosis
Start date
2020-04-01
Primary completion
2024-09-25
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.